Wild-type α-synuclein interacts with pro-apoptotic proteins PKCδ and BAD to protect dopaminergic neuronal cells against MPP +-induced apoptotic cell death

Molecular Brain Research

Volumn 139, Issue 1, 2005, Pages 137-152

  Kaul, Siddharth ^a   Anantharam, Vellareddy ^a   Kanthasamy, Arthi ^a   Kanthasamy, Anumantha G ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Alpha synuclein; Apoptosis; Neurodegeneration; Neurotoxicity; Oxidative stress; Parkinson's disease; PKC; Protease; Protein interaction; Signal transduction

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ALPHA SYNUCLEIN; CASPASE 3; CYTOCHROME C; DNA FRAGMENT; PROTEIN BAD; PROTEIN BCL 2; PROTEIN KINASE C DELTA; REACTIVE OXYGEN METABOLITE; RECOMBINANT ENZYME;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOPRECIPITATION; MESENCEPHALON; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 25644442285     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2005.05.022     Document Type: Article

References (103)

1. A. Abeliovich, Y. Schmitz, I. Farinas, D. Choi-Lundberg, W.H. Ho, P.E. Castillo, N. Shinsky, J.M. Verdugo, M. Armanini, A. Ryan, M. Hynes, H. Phillips, D. Sulzer, A. Rosenthal, Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system, Neuron 25 (2000) 239-252.
2. D. Albani, E. Peverelli, R. Rametta, S. Batelli, L. Veschini, A. Negro, G. Forloni, Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70, FASEB J. 18 (2004) 1713-1715.
3. D.S. Albers, M.F. Beal, Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease, J. Neural Transm., Suppl. 59 (2000) 133-154.
4. C. Alves Da Costa, E. Paitel, B. Vincent, F. Checler, Alpha-synuclein lowers p53-dependent apoptotic response in neuronal cells: abolishment by 6-hydroxydopamine and implication for Parkinson's disease, J. Biol. Chem. 279 (2002) 50980-50984.
5. V. Anantharam, M. Kitazawa, J. Wagner, S. Kaul, A.G. Kanthasamy, Caspase-3-dependent proteolytic cleavage of protein kinase Cdelta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl, J. Neurosci. 22 (2002) 1738-1751.
6. C.M. Barrett, F.L. Lewis, J.B. Roaten, T.W. Sweatman, M. Israel, J.L. Cleveland, L. Lothstein, Novel extranuclear-targeted anthracyclines override the antiapoptotic functions of Bcl-2 and target protein kinase C pathways to induce apoptosis, Mol. Cancer Ther. 1 (2002) 469-481.
7. R. Betarbet, T.B. Sherer, J.T. Greenamyre, Animal models of Parkinson's disease, BioEssays 24 (2002) 308-318.
8. A. Bharti, S.K. Kraeft, M. Gounder, P. Pandey, S. Jin, Z.M. Yuan, S.P. Lees-Miller, R. Weichselbaum, D. Weaver, L.B. Chen, D. Kufe, S. Kharbanda, Inactivation of DNA-dependent protein kinase by protein kinase Cdelta: implications for apoptosis, Mol. Cell. Biol. 18 (1998)6719-6728.
9. N.W. Blackstone, D.R. Green, The evolution of a mechanism of cell suicide, BioEssays 21 (1999) 84-88.
10. I. Budihardjo, H. Oliver, M. Lutter, X. Luo, X. Wang, Biochemical pathways of caspase activation during apoptosis, Annu. Rev. Cell Dev. Biol. 15 (1999) 269-290.
11. R. Bussell Jr., D. Eliezer, A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins, J. Mol. Biol. 329 (2003) 763-778.
12. D.S. Cassarino, J.P. Bennett Jr., An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration, Brain Res. Brain Res. Rev. 29 (1999) 1-25.
13. P.E. Chen, C.G. Specht, R.G. Morris, R. Schoepfer, Spatial learning is unimpaired in mice containing a deletion of the alpha-synuclein locus, Eur. J. Neurosci. 16 (2002) 154-158.
14. W.S. Choi, L.M. Canzoniero, S.L. Sensi, K.L. O'Malley, B.J. Gwag, S. Sohn, J.E. Kim, T.H. Oh, E.B. Lee, Y.J. Oh, Characterization of MPP(+)-induced cell death in a dopaminergic neuronal cell line: role of macromolecule synthesis, cytosolic calcium, caspase, and Bcl-2-related proteins, Exp. Neurol. 159 (1999) 274-282.
15. G.M. Cohen, Caspases: the executioners of apoptosis, Biochem. J. 326 (1997) 1-16.
16. F. Condorelli, P. Salomoni, S. Cotteret, V. Cesi, S.M. Srinivasula, E.S. Alnemri, B. Calabretta, Caspase cleavage enhances the apoptosis-inducing effects of BAD, Mol. Cell. Biol. 21 (2001) 3025-3036.
17. K.A. Conway, J.C. Rochet, R.M. Bieganski, P.T. Lansbury Jr., Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct, Science 294 (2001) 1346-1349.
18. M. Crompton, The mitochondrial permeability transition pore and its role in cell death, Biochem. J. 341 (1999) 233-249.
19. T. Cross, G. Griffiths, E. Deacon, R. Sallis, M. Gough, D. Watters, J.M. Lord, PKC-delta is an apoptotic lamin kinase, Oncogene 19 (2000) 2331-2337.
20. C.A. da Costa, K. Ancolio, F. Checler, Wild-type but not Parkinson's disease-related ala-53→Thr mutant alpha-synuclein protects neuronal cells from apoptotic stimuli, J. Biol. Chem. 275 (2000) 24065-24069.
21. S.R. Datta, A.M. Ranger, M.Z. Lin, J.F. Sturgill, Y.C. Ma, C.W. Cowan, P. Dikkes, S.J. Korsmeyer, M.E. Greenberg, Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis, Dev. Cell 3 (2002) 631-643.
22. T.M. Dawson, V.L. Dawson, Rare genetic mutations shed light on the pathogenesis of Parkinson disease, J. Clin. Invest. 111 (2003) 145-151.
23. R. Dawson Jr., M.F. Beal, S.C. Bondy, D.A. Di Monte, G.E. Isom, Excitotoxins, aging, and environmental neurotoxins: implications for understanding human neurodegenerative diseases, Toxicol. Appl. Pharmacol. 134 (1995) 1-17.
24. R.E. Drolet, B. Behrouz, K.J. Lookingland, J.L. Goudreau, Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration, Neurotoxicology 25 (2004) 761-769.
25. W.C. Earnshaw, L.M. Martins, S.H. Kaufmann, Mammalian caspases: structure, activation, substrates, and functions during apoptosis, Annu. Rev. Biochem. 68 (1999) 383-424.
26. H. Elkon, J. Don, E. Melamed, I. Ziv, A. Shirvan, D. Offen, Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome C oxidase, J. Mol. Neurosci. 18 (2002) 229-238.
27. G. Fiskum, A. Starkov, B.M. Polster, C. Chinopoulos, Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease, Ann. N. Y. Acad. Sci. 991 (2003) 111-119.
28. L.F. Garcia-Fernandez, A. Losada, V. Alcaide, A.M. Alvarez, A. Cuadrado, L. Gonzalez, K. Nakayama, K.I. Nakayama, J.M. Fernandez-Sousa, A. Munoz, J.M. Sanchez-Puelles, Aplidin induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C delta, Oncogene 21 (2002)7533-7544.
29. J.M. George, H. Jin, W.S. Woods, D.F. Clayton, Characterization of a novel protein regulated during the critical period for song learning in the zebra finch, Neuron 15 (1995) 361-372.
30. M. Goedert, Alpha-synuclein and neurodegenerative diseases, Nat. Rev. Neurosci. 2 (2001) 492-501.
31. C. Gomez-Santos, I. Ferrer, J. Reiriz, F. Vinals, M. Barrachina, S. Ambrosio, MPP+ increases alpha-synuclein expression and ERK/-MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells, Brain Res. 935 (2002) 32-39.
32. J.T. Greenamyre, G. MacKenzie, T.I. Peng, S.E. Stephans, Mitochondrial dysfunction in Parkinson's disease, Biochem. Soc. Symp. 66(1999)85-97.
33. A. Hartmann, S. Hunot, P.P. Michel, M.P. Muriel, S. Vyas, B.A. Faucheux, A. Mouatt-Prigent, H. Turmel, A. Srinivasan, M. Ruberg, G.I. Evan, Y. Agid, E.C. Hirsch, Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease, Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 2875-2880.
34. M. Hashimoto, A. Takeda, L.J. Hsu, T. Takenouchi, E. Masliah, Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease, J. Biol. Chem. 274 (1999) 28849-28852.
35. M. Hashimoto, L.J. Hsu, E. Rockenstein, T. Takenouchi, M. Mallory, E. Masliah, Alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells, J. Biol. Chem. 277 (2002) 11465-11472.
36. M. Hashimoto, E. Rockenstein, M. Mante, L. Crews, P. Bar-On, F.H. Gage, R. Marr, E. Masliah, An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model, Gene Ther. 11 (2004) 1713-1723.
37. H. Ischiropoulos, J.S. Beckman, Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J. Clin. Invest. 111 (2003) 163-169.
38. A. Iwata, M. Maruyama, I. Kanazawa, N. Nukina, Alpha-Synuclein affects the MAPK pathway and accelerates cell death, J. Biol. Chem. 276 (2001) 45320-45329.
39. A. Iwata, S. Miura, I. Kanazawa, M. Sawada, N. Nukina, Alpha-Synuclein forms a complex with transcription factor Elk-1, J. Neurochem. 77 (2001) 239-252.
40. R. Jakes, M.G. Spillantini, M. Goedert, Identification of two distinct synucleins from human brain, FEBS Lett. 345 (1994) 27-32.
41. B.C. Jang, E.S. Choi, K.J. Im, W.K. Baek, T.K. Kwon, M.H. Suh, S.P. Kim, J.W. Park, S.I. Suh, Induction of apoptosis by Se-MSC in U937 human leukemia cells through release of cytochrome c and activation of caspases and PKC-delta: mutual regulation between caspases and PKC-delta via a positive feedback mechanism, Int. J. Mol. Med. 12 (2003) 733-739.
42. P. Jenner, Oxidative stress in Parkinson's disease, Ann. Neurol. 53 (Suppl. 3) (2003) S26-S36 (discussion S36-S38).
43. P. Jenner, C.W. Olanow, Oxidative stress and the pathogenesis of Parkinson's disease, Neurology 47 (1996) S161-S170.
44. P.H. Jensen, W.P. Gai, Alpha-synuclein. Axonal transport, ligand interaction and neurodegeneration, Adv. Exp. Med. Biol. 487 (2001) 129-134.
45. P.J. Jensen, B.J. Alter, K.L. O'Malley, Alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity, J. Neurochem. 86 (2003) 196-209.
46. E. Junn, M.M. Mouradian, Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine, Neurosci. Lett. 320 (2002) 146-150.
47. S. Kanda, J.F. Bishop, M.A. Eglitis, Y. Yang, M.M. Mouradian, Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation, Neuroscience 97 (2000) 279-284.
48. B. Kaplan, V. Ratner, E. Haas, Alpha-synuclein: its biological function and role in neurodegenerative diseases, J. Mol. Neurosci. 20 (2003) 83-92.
49. S. Kaul, V. Anantharam, A.G. Kanthasamy, Wild-type alpha-synuclein prevents MPP+ induced proteolytic activation of PKCδ and cellular apoptosis in neuronal cells, 32nd Annual Meeting of Society for Neuroscience, Orlando, FL, 2002.
50. S. Kaul, A. Kanthasamy, M. Kitazawa, V. Anantharam, A.G. Kanthasamy, Caspase-3 dependent proteolytic activation of protein kinase Cdelta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration, Eur. J. Neurosci. 18 (2003) 1387-1401.
51. M. Kitazawa, V. Anantharam, A.G. Kanthasamy, Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration, Neuroscience 119 (2003) 945-964.
52. L. Ko, N.D. Mehta, M. Farrer, C. Easson, J. Hussey, S. Yen, J. Hardy, S.H. Yen, Sensitization of neuronal cells to oxidative stress with mutated human alpha-synuclein, J. Neurochem. 75 (2000) 2546-2554.
53. R. Kruger, W. Kuhn, T. Muller, D. Woitalla, M. Graeber, S. Kosel, H. Przuntek, J.T. Epplen, L. Schols, O. Riess, Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease, Nat. Genet. 18 (1998) 106-108.
54. J.W. Langston, Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate, Ann. Neurol. 44 (1998) S45-S52.
55. J.W. Langston, S. Sastry, P. Chan, L.S. Forno, L.M. Bolin, D.A. Di Monte, Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease, Exp. Neurol. 154 (1998) 684-690.
56. H.C. Lee, Y.H. Wei, Mitochondrial role in life and death of the cell, J. Biomed Sci. 7 (2000) 2-15.
57. Z. Li, H. Lin, Y. Zhu, M. Wang, J. Luo, Disruption of cell cycle kinetics and cyclin-dependent kinase system by ethanol in cultured cerebellar granule progenitors, Brain Res. Dev. Brain Res. 132 (2001) 47-58.
58. A.S. Mandir, S. Przedborski, V. Jackson-Lewis, Z.Q. Wang, C.M. Simbulan-Rosenthal, M.E. Smulson, B.E. Hoffman, D.B. Guastella, V.L. Dawson, T.M. Dawson, Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism, Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 5774-5779.
59. A.B. Manning-Bog, A.L. McCormack, M.G. Purisai, L.M. Bolin, D.A. Di Monte, Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration, J. Neurosci. 23 (2003) 3095-3099.
60. E. Maries, B. Dass, T.J. Collier, J.H. Kordower, K. Steece-Collier, The role of alpha-synuclein in Parkinson's disease: insights from animal models, Nat. Rev. Neurosci. 4 (2003) 727-738.
61. L. Maroteaux, J.T. Campanelli, R.H. Scheller, Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal, J. Neurosci. 8 (1988) 2804-2815.
62. VS. Marsden, L. O'Connor, L.A. O'Reilly, J. Silke, D. Metcalf, P.G. Ekert, D.C. Huang, F. Cecconi, K. Kuida, K.J. Tomaselli, S. Roy, D.W. Nicholson, D.L. Vaux, P. Bouillet, J.M. Adams, A. Strasser, Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome, Nature 419 (2002) 634-637.
63. D. Matassov, T. Kagan, J. Leblanc, M. Sikorska, Z. Zakeri, Measurement of apoptosis by DNA fragmentation, Methods Mol. Biol. 282 (2004) 1-17.
64. Y. Matsuoka, M. Vila, S. Lincoln, A. McCormack, M. Picciano, J. LaFrancois, X. Yu, D. Dickson, W.J. Langston, E. McGowan, M. Farrer, J. Hardy, K. Duff, S. Przedborski, D.A. Di Monte, Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter, Neurobiol. Dis. 8 (2001) 535-539.
65. A.L. McCormack, M. Thiruchelvam, A.B. Manning-Bog, C. Thiffault, J.W. Langston, D.A. Cory-Slechta, D.A. Di Monte, Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat, Neurobiol. Dis. 10 (2002) 119-127.
66. P.K. Narayanan, E.H. Goodwin, B.E. Lehnert, Alpha particles initiate biological production of superoxide anions and hydrogen peroxide in human cells, Cancer Res. 57 (1997) 3963-3971.
67. M. Nomura, S. Shimizu, T. Sugiyama, M. Narita, T. Ito, H. Matsuda, Y. Tsujimoto, 14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax, J. Biol. Chem. 278 (2003) 2058-2065.
68. Y. Ogawa, A. Nishioka, T. Kobayashi, S. Kariya, S. Hamasato, T. Saibara, K. Nakayama, H. Seguchi, S. Yoshida, Mitochondrial cytochrome c release in radiation-induced apoptosis of human peripheral T cells, Int. J. Mol. Med. 10 (2002) 263-268.
69. N. Ostrerova, L. Petrucelli, M. Farrer, N. Mehta, P. Choi, J. Hardy, B. Wolozin, Alpha-Synuclein shares physical and functional homology with 14-3-3 proteins, J. Neurosci. 19 (1999) 5782-5791.
70. N. Ostrerova-Golts, L. Petrucelli, J. Hardy, J.M. Lee, M. Farer, B. Wolozin, The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity, J. Neurosci. 20 (2000) 6048-6054.
71. R.G. Perez, J.C. Waymire, E. Lin, J.J. Liu, F. Guo, M.J. Zigmond, A role for alpha-synuclein in the regulation of dopamine biosynthesis, J. Neurosci. 22 (2002) 3090-3099.
72. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E. S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W.G. Johnson, A.M. Lazzarini, R.C. Duvoisin, G. Di Iorio, L.I. Golbe, R.L. Nussbaum, Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science 276 (1997) 2045-2047.
73. K.N. Prasad, E.D. Clarkson, F.G. La Rosa, J. Edwards-Prasad, C.R. Freed, Efficacy of grafted immortalized dopamine neurons in an animal model of parkinsonism: a review, Mol. Genet. Metab. 65 (1998) 1-9.
74. J. Ren, R. Datta, H. Shioya, Y. Li, E. Oki, V. Biedermann, A. Bharti, D. Kufe, p73beta is regulated by protein kinase Cdelta catalytic fragment generated in the apoptotic response to DNA damage, J. Biol. Chem. 277 (2002) 33758-33765.
75. M.E. Reyland, S.M. Anderson, A.A. Matassa, K.A. Barzen, D.O. Quissell, Protein kinase C delta is essential for etoposide-induced apoptosis in salivary gland acinar cells, J. Biol. Chem. 274 (1999) 19115-19123.
76. D.W. Rickman, R.E. Nacke, C.B. Rickman, Characterization of the cell death promoter, Bad, in the developing rat retina and forebrain, Brain Res. Dev. Brain Res. 115 (1999) 41-47.
77. D.C. Robertson, O. Schmidt, N. Ninkina, P.A. Jones, J. Sharkey, V.L. Buchman, Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice, J. Neurochem. 89 (2004) 1126-1136.
78. B.L. Roth, M. Poot, S.T. Yue, P.J. Millard, Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain, Appl. Environ. Microbiol. 63 (1997) 2421-2431.
79. B. Schilling, M.M.S. Bharath, R.H. Row, J. Murray, M.P. Cusack, R.A. Capaldi, C.R. Freed, K.N. Prasad, J.K. Andersen, B.W. Gibson, Rapid purification and mass spectrometric characterization of mitochondrial NADH dehydrogenase (Complex I) from rodent brain and a dopaminergic neuronal cell line, Mol. Cell. Proteomics 4 (2005) 84-96.
80. J.H. Seo, J.C. Rah, S.H. Choi, J.K. Shin, K. Min, H.S. Kim, C.H. Park, S. Kim, E.M. Kim, S.H. Lee, S. Lee, S.W. Suh, YH. Suh, Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway, FASEB J. 16 (2002) 1826-1828.
81. T.B. Sherer, R. Betarbet, A.K. Stout, S. Lund, M. Baptista, A.V. Panov, M.R. Cookson, J.T. Greenamyre, An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage, J. Neurosci. 22 (2002) 7006-7015.
82. A.B. Singleton, M. Farrer, J. Johnson, A. Singleton, S. Hague, J. Kachergus, M. Hulihan, T Peuralinna, A. Dutra, R. Nussbaum, S. Lincoln, A. Crawley, M. Hanson, D. Maraganore, C. Adler, M.R. Cookson, M. Muenter, M. Baptista, D. Miller, J. Blancato, J. Hardy, K. Gwinn-Hardy, Alpha-Synuclein locus triplication causes Parkinson's disease, Science 302 (2003) 841.
83. S. Speciale, MPTP. Insights into parkinsonian neurodegeneration, Neurotoxicol. Teratol. 24 (2002) 607.
84. M.G. Spillantini, M. Goedert, The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, Ann. N. Y. Acad. Sci. 920 (2000) 16-27.
85. S.M. Srinivasula, M. Ahmad, T. Fernandes-Alnemri, E.S. Alnemri, Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization, Mol. Cell 1 (1998) 949-957.
86. C.M. Tanner, R. Ottman, S.M. Goldman, J. Ellenberg, P. Chan, R. Mayeux, J.W. Langston, Parkinson disease in twins: an etiologic study, JAMA 281 (1999) 341-346.
87. M.J. Thiruchelvam, J.M. Powers, D.A. Cory-Slechta, E.K. Richfield, Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice, Eur. J. Neurosci. 19 (2004) 845-854.
88. J.Q. Trojanowski, M. Goedert, T. Iwatsubo, V.M. Lee, Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia, Cell Death Differ. 5 (1998) 832-837.
89. M. Vila, D.C. Wu, S. Przedborski, Engineered modeling and the secrets of Parkinson's disease, Trends Neurosci. 24 (2001) S49-S55.
90. V. Viswanath, Y. Wu, R. Boonplueang, S. Chen, F.F. Stevenson, F. Yantiri, L. Yang, M.F. Beat, J.K. Andersen, Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced Parkinson's disease, J. Neurosci. 21 (2001) 9519-9528.
91. O. von Bohlen und Halbach, A. Schober, K. Krieglstein, Genes, proteins, and neurotoxins involved in Parkinson's disease, Prog. Neurobiol. 73 (2004) 151-177.
92. K. Wakabayashi, S. Engelender, Y. Tanaka, M. Yoshimoto, F. Mori, S. Tsuji, C.A. Ross, H. Takahashi, Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders, Acta Neuropathol. (Berl.) 103 (2002) 209-214.
93. P.H. Weinreb, W. Zhen, A.W. Poon, K.A. Conway, P.T. Lansbury Jr., NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded, Biochemistry 35 (1996) 13709-13715.
94. C. Wersinger, A. Sidhu, Differential cytotoxicity of dopamine and H2O2 in a human neuroblastoma divided cell line transfected with alpha-synuclein and its familial Parkinson's disease-linked mutants, Neurosci. Lett. 342 (2003) 124-128.
95. X.G. Xia, T. Harding, M. Weller, A. Bieneman, J.B. Uney, J.B. Schulz, Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease, Proc. Natl. Acad. Sei. U. S. A. 98 (2001) 10433-10438.
96. +-induced dopaminergic degeneration, Mol. Cell. Neurosci. 25 (2004) 406-421.
97. S. Yoshimura, Y. Banno, S. Nakashima, K. Takenaka, H. Sakai, Y. Nishimura, N. Sakai, S. Shimizu, Y. Eguchi, Y. Tsujimoto, Y. Nozawa, Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death. Inhibitory effects of Bcl-2 on ceramide formation and caspase-3 activation, J. Biol. Chem. 273 (1998) 6921-6927.
98. J. Yuan, B.A. Yankner, Apoptosis in the nervous system, Nature 407 (2000)802-809.
99. J.J. Zarranz, J. Alegre, J.C. Gomez-Esteban, E. Lezcano, R. Ros, I. Ampuero, L. Vidal, J. Hoenicka, O. Rodriguez, B. Atares, V. Llorens, E. Gomez Tortosa, T. del Ser, D.G. Munoz, J.G. de Yebenes, The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia, Ann. Neurol. 55 (2004) 164-173.
100. J. Zha, H. Harada, E. Yang, J. Jockel, S.J. Korsmeyer, Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L), Cell 87 (1996) 619-628.
101. J. Zhang, G. Perry, M.A. Smith, D. Robertson, S.J. Olson, D.G. Graham, T.J. Montine, Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons, Am. J. Pathol. 154 (1999) 1423-1429.
102. W. Zhou, J. Schaack, W.M. Zawada, C.R. Freed, Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture, Brain Res. 926 (2002) 42-50.
103. M.J. Zigmond, When it comes to communications between neurons, synapses are over-rated: insights from an animal model of parkinsonism, Prog. Brain Res. 125 (2000) 317-326.